Pharmacovigilance in Israel – tools, processes, and actions-Reference-Cited by-同舟云学术

Pharmacovigilance in Israel – tools, processes, and actions

Published:2017-08-01 Issue:1 Volume:6 Page:
ISSN:2045-4015
Container-title:Israel Journal of Health Policy Research
language:en
Short-container-title:Isr J Health Policy Res

Author:

Schwartzberg Eyal,Berkovitch Matitiahu,Dil Nahlieli Dorit,Nathan Joseph,Gorelik Einat

Publisher

Springer Science and Business Media LLC

Subject

Public Health, Environmental and Occupational Health,Health Policy

Link

http://link.springer.com/content/pdf/10.1186/s13584-017-0154-3.pdf

Reference16 articles.

1. World Health Organization. The WHO Programme for International Drug Monitoring. http://www.who.int/medicines/areas/quality_safety/safety_efficacy/National_PV_Centres_Map/en/ . Accessed 20 Apr 2017.

2. World Health Organization. Vaccine safety course: Module 5. http://vaccine-safety-training.org/who-programme-for-international-drug-monitoring.html . Accessed 20 Apr 2017.

3. World Health Organization. Glossary of pharmacovigilance terms. https://www.who-umc.org/global-pharmacovigilance/global-pharmacovigilance/glossary/ . Accessed 20 Apr 2017.

4. Safety monitoring of medicines. http://www.ema.europa.eu/ema/index.jsp?curl=pages/special_topics/general/general_content_000456.jsp&mid=WC0b01ac05801ae8fb . Accessed 7 Nov 2016

5. Access to EudraVigilance data. http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000674.jsp&mid=WC0b01ac0580a69390 . Accessed 18 Dec 2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacovigilance in High-Income Countries: Current Developments and a Review of Literature;Pharmacy;2023-01-06

2. Opportunities and challenges of pharmacovigilance in special populations: a narrative review of the literature;Therapeutic Advances in Drug Safety;2023-01

3. Spontaneous reporting of adverse drug reactions as an outlet for patient dismay? The case of Levothyrox® change of excipients;Fundamental & Clinical Pharmacology;2022-01-18

4. Increasing adverse drug reaction reporting—How can we do better?;PLOS ONE;2020-08-13

5. Pharmacovigilance strategy: opportunities for cross-national learning;Israel Journal of Health Policy Research;2019-06-19